Trial Information

Summary: A Two-Arm, Open-Label, Randomized, Multi-Center Pharmacokinetic and Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate In Hypogonadal Men

We are conducting a study for men who have been diagnosed with low testosterone. The study is testing the safety and efficacy of an investigational medication for the treatment of Hypogonadism which is characterized by low testosterone levels. All study related office visits, study medication, lab work and procedures are provided at no cost to participants.

Please note that you cannot participate in this study if:

• Under the age of 18
• Serum testosterone levels are greater than 300ng/dL
• Unable or unwilling to stop any current replacement hormones
• Have sleep apnea, insulin-dependent diabetes or prostate tumors

If you are interested in learning more about this study,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.